APA (7th ed.) Citation

KE, M., KM, S., O, G., DP, R., CE, C., JR, L., . . . ER, M. (2021). Clinical response to dabrafenib plus trametinib in a pediatric ganglioglioma with BRAF p.T599dup mutation. Cold Spring Harbor molecular case studies, 7(2), . https://doi.org/10.1101/mcs.a006023

Chicago Style (17th ed.) Citation

KE, Miller, Schieffer KM, Grischow O, Rodriguez DP, Cottrell CE, Leonard JR, Finlay JL, and Mardis ER. "Clinical Response to Dabrafenib Plus Trametinib in a Pediatric Ganglioglioma with BRAF P.T599dup Mutation." Cold Spring Harbor Molecular Case Studies 7, no. 2 (2021). https://doi.org/10.1101/mcs.a006023.

MLA (9th ed.) Citation

KE, Miller, et al. "Clinical Response to Dabrafenib Plus Trametinib in a Pediatric Ganglioglioma with BRAF P.T599dup Mutation." Cold Spring Harbor Molecular Case Studies, vol. 7, no. 2, 2021, https://doi.org/10.1101/mcs.a006023.